FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325267532> ?p ?o ?g. }

• W2325267532 endingPage "e1554" @default.
• W2325267532 startingPage "e1554" @default.
• W2325267532 abstract "Adult-onset Still's disease (AOSD) is often refractory to standard therapy. Anakinra (ANK), an interleukin-1 receptor antagonist, has demonstrated efficacy in single cases and small series of AOSD. We assessed the efficacy of ANK in a series of AOSD patients. Multicenter retrospective open-label study. ANK was used due to lack of efficacy to standard synthetic immunosuppressive drugs and in some cases also to at least 1 biologic agent. Forty-one patients (26 women/15 men) were recruited. They had a mean age of 34.4 ± 14 years and a median [interquartile range (IQR)] AOSD duration of 3.5 [2-6] years before ANK onset. At that time the most common clinical features were joint manifestations 87.8%, fever 78%, and cutaneous rash 58.5%. ANK yielded rapid and maintained clinical and laboratory improvement. After 1 year of therapy, the frequency of joint and cutaneous manifestations had decreased to 41.5% and to 7.3% respectively, fever from 78% to 14.6%, anemia from 56.1% to 9.8%, and lymphadenopathy from 26.8% to 4.9%. A dramatic improvement of laboratory parameters was also achieved. The median [IQR] prednisone dose was also reduced from 20 [11.3-47.5] mg/day at ANK onset to 5 [0-10] at 12 months. After a median [IQR] follow-up of 16 [5-50] months, the most important side effects were cutaneous manifestations (n = 8), mild leukopenia (n = 3), myopathy (n = 1), and infections (n = 5). ANK is associated with rapid and maintained clinical and laboratory improvement, even in nonresponders to other biologic agents. However, joint manifestations are more refractory than the systemic manifestations." @default.
• W2325267532 created "2016-06-24" @default.
• W2325267532 creator A5002102037 @default.
• W2325267532 creator A5005535914 @default.
• W2325267532 creator A5005767315 @default.
• W2325267532 creator A5006888939 @default.
• W2325267532 creator A5012858626 @default.
• W2325267532 creator A5013522529 @default.
• W2325267532 creator A5016922988 @default.
• W2325267532 creator A5021254779 @default.
• W2325267532 creator A5025004560 @default.
• W2325267532 creator A5028113781 @default.
• W2325267532 creator A5033087285 @default.
• W2325267532 creator A5036391823 @default.
• W2325267532 creator A5041005014 @default.
• W2325267532 creator A5043005051 @default.
• W2325267532 creator A5046280874 @default.
• W2325267532 creator A5048359064 @default.
• W2325267532 creator A5048645990 @default.
• W2325267532 creator A5049778476 @default.
• W2325267532 creator A5055675006 @default.
• W2325267532 creator A5061815657 @default.
• W2325267532 creator A5064034739 @default.
• W2325267532 creator A5065596527 @default.
• W2325267532 creator A5073900189 @default.
• W2325267532 creator A5079269545 @default.
• W2325267532 creator A5082655077 @default.
• W2325267532 creator A5084892409 @default.
• W2325267532 creator A5085520437 @default.
• W2325267532 creator A5087708698 @default.
• W2325267532 creator A5087919662 @default.
• W2325267532 creator A5088774740 @default.
• W2325267532 creator A5054814433 @default.
• W2325267532 creator A5086603256 @default.
• W2325267532 date "2015-09-01" @default.
• W2325267532 modified "2023-10-18" @default.
• W2325267532 title "Efficacy of Anakinra in Refractory Adult-Onset Still's Disease" @default.
• W2325267532 cites W1605817481 @default.
• W2325267532 cites W1614943507 @default.
• W2325267532 cites W1980597439 @default.
• W2325267532 cites W2003892414 @default.
• W2325267532 cites W2008945784 @default.
• W2325267532 cites W2026949371 @default.
• W2325267532 cites W2038796481 @default.
• W2325267532 cites W2048698451 @default.
• W2325267532 cites W2049803113 @default.
• W2325267532 cites W2107770711 @default.
• W2325267532 cites W2125372614 @default.
• W2325267532 cites W2133938345 @default.
• W2325267532 cites W2143826719 @default.
• W2325267532 cites W2145249112 @default.
• W2325267532 cites W2146620925 @default.
• W2325267532 cites W2166106092 @default.
• W2325267532 cites W2227912200 @default.
• W2325267532 cites W2267319559 @default.
• W2325267532 cites W2297140111 @default.
• W2325267532 cites W2331916323 @default.
• W2325267532 cites W2394646884 @default.
• W2325267532 cites W4293429475 @default.
• W2325267532 doi "https://doi.org/10.1097/md.0000000000001554" @default.
• W2325267532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4616841" @default.
• W2325267532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26426623" @default.
• W2325267532 hasPublicationYear "2015" @default.
• W2325267532 type Work @default.
• W2325267532 sameAs 2325267532 @default.
• W2325267532 citedByCount "86" @default.
• W2325267532 countsByYear W23252675322015 @default.
• W2325267532 countsByYear W23252675322016 @default.
• W2325267532 countsByYear W23252675322017 @default.
• W2325267532 countsByYear W23252675322018 @default.
• W2325267532 countsByYear W23252675322019 @default.
• W2325267532 countsByYear W23252675322020 @default.
• W2325267532 countsByYear W23252675322021 @default.
• W2325267532 countsByYear W23252675322022 @default.
• W2325267532 countsByYear W23252675322023 @default.
• W2325267532 crossrefType "journal-article" @default.
• W2325267532 hasAuthorship W2325267532A5002102037 @default.
• W2325267532 hasAuthorship W2325267532A5005535914 @default.
• W2325267532 hasAuthorship W2325267532A5005767315 @default.
• W2325267532 hasAuthorship W2325267532A5006888939 @default.
• W2325267532 hasAuthorship W2325267532A5012858626 @default.
• W2325267532 hasAuthorship W2325267532A5013522529 @default.
• W2325267532 hasAuthorship W2325267532A5016922988 @default.
• W2325267532 hasAuthorship W2325267532A5021254779 @default.
• W2325267532 hasAuthorship W2325267532A5025004560 @default.
• W2325267532 hasAuthorship W2325267532A5028113781 @default.
• W2325267532 hasAuthorship W2325267532A5033087285 @default.
• W2325267532 hasAuthorship W2325267532A5036391823 @default.
• W2325267532 hasAuthorship W2325267532A5041005014 @default.
• W2325267532 hasAuthorship W2325267532A5043005051 @default.
• W2325267532 hasAuthorship W2325267532A5046280874 @default.
• W2325267532 hasAuthorship W2325267532A5048359064 @default.
• W2325267532 hasAuthorship W2325267532A5048645990 @default.
• W2325267532 hasAuthorship W2325267532A5049778476 @default.
• W2325267532 hasAuthorship W2325267532A5054814433 @default.
• W2325267532 hasAuthorship W2325267532A5055675006 @default.
• W2325267532 hasAuthorship W2325267532A5061815657 @default.
• W2325267532 hasAuthorship W2325267532A5064034739 @default.

• next